US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Yuanbao Inc.

12.44

+0.36002.98%

Post-market: 12.680.2400+1.93%17:01 EDT

Volume:40.55K

Turnover:488.57K

Market Cap:573.24M

PE:2.72

High:12.44

Open:12.02

Low:11.56

Close:12.08

52wk High:24.40

52wk Low:11.56

Shares:46.08M

Float Shares:8.20M

Volume Ratio:2.37

T/O Rate:0.49%

Dividend:1.26

Dividend Rate:10.15%

EPS(TTM):4.57

EPS(LYR):3.92

ROE:47.21%

ROA:20.70%

PB:1.02

PE(LYR):3.17

Loading ...

Overview Company News Filings

Hashrate Hurdle Rises 4.7%: Bitcoin Must Clear $82,900 to Preserve Miner Margins

Yuanbao, Inc. Earnings Call Highlights AI-Led Growth

Yuanbao Q2 FY26 Net Income Rises 35.6% to RMB 413.2 Million; Revenue Increases 30.1% to RMB 1.39 Billion

Yuanbao Q2 Adj. EPS $1.32 Up From $0.97 YoY, Sales $205.182M Up From $149.356M YoY

Benzinga Earnings

Yuanbao - Q2 2026 Total Revenues up 30.1% to Rmb1,392.2 Mln (us$205.2 Mln)

THOMSON REUTERS

Yuanbao Inc. Announces Second Quarter 2026 Unaudited Financial Results

THOMSON REUTERS

Yarrow Bioscience’s YB-101 Trial Targets Graves’ Disease, Raising New Investor Interest

Yuanbao to Report Q2 2026 Results, Host Earnings Call

Yuanbao Inc. to Announce Second Quarter 2026 Financial Results on Thursday, September 10, 2026

YB Ventures Malaysia 4th-Quarter 2026 Earnings Summary Table

Press Release: Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update

Yarrow Bioscience initiated with a Buy at TD Cowen

Yarrow Bioscience Finalizes Merger with VYNE, Starts Phase 2 Trial for Graves' Disease Drug YB-101

Yarrow Bioscience Completes VYNE Therapeutics Merger, Begins Phase 2 Trial Dosing for YB-101

MT Newswires Live

Press Release: Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of Yb-101, a Potential First-in-Class Treatment for Graves' Disease and Thyroid Eye Disease

Stocks Ex-dividend July 2

Yuanbao, Inc. Earnings Call Highlights AI-Powered Surge

Yuanbao Inc. Posts Strong Q1 2026 Results and Deepens AI Push in Online Insurance

Yuanbao to remain focused on high-quality revenue growth

Yuanbao announces $15M share repurchase program

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/YB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"YB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YB\",,,,,undefined,":{"symbol":"YB","market":"US","secType":"STK","nameCN":"Yuanbao Inc.","latestPrice":12.44,"timestamp":1790798400000,"preClose":12.08,"halted":0,"volume":40553,"hourTrading":{"tag":"盘后","latestPrice":12.68,"preClose":12.44,"latestTime":"17:01 EDT","volume":104,"amount":1293.999928,"timestamp":1790802063541,"change":0.24,"changeRate":0.019293,"amplitude":0.019293},"delay":0,"changeRate":0.029801324503311213,"floatShares":8200500,"shares":46080200,"eps":4.570043,"marketStatus":"Post-Mkt","change":0.36,"latestTime":"09-30 18:58:55 EDT","open":12.02,"high":12.44,"low":11.5584,"amount":488572.040773,"amplitude":0.07298,"askPrice":13,"askSize":200,"bidPrice":11.55,"bidSize":1,"shortable":3,"etf":0,"ttmEps":4.570043,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":4,"adr":0,"adrRate":6,"listingDate":1745985600000,"exchange":"NASDAQ","adjPreClose":12.08,"dividendRate":0.101487,"preHourTrading":{"tag":"盘前","latestPrice":11.9001,"preClose":12.08,"latestTime":"09:27 EDT","volume":28,"amount":333.2028,"timestamp":1790774851315,"change":-0.1799,"changeRate":-0.014892,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":12.68,"preClose":12.44,"latestTime":"17:01 EDT","volume":104,"amount":1293.999928,"timestamp":1790802063541,"change":0.24,"changeRate":0.019293,"amplitude":0.019293},"volumeRatio":2.365103},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YB\",,,,,undefined,":{"symbol":"YB","floatShares":8200500,"roa":"20.70%","roe":"47.21%","lyrEps":3.923177,"volumeRatio":2.365103,"shares":46080200,"dividePrice":1.2625,"high":12.44,"amplitude":0.07298,"preClose":12.08,"low":11.5584,"week52Low":11.5584,"pbRate":"1.02","psRate":"0.76","week52High":24.4,"institutionHeld":0,"latestPrice":12.44,"committee":-0.99005,"eps":4.570043,"divideRate":0.101487,"volume":40553,"delay":0,"ttmEps":4.570043,"open":12.02,"prevYearClose":20.26,"prevWeekClose":12.215,"prevMonthClose":13.84,"prevQuarterClose":15.24,"fiveDayClose":12.21,"twentyDayClose":13.63,"sixtyDayClose":14.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/YB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-09-10","symbol":"YB","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1789012800000,"reportTimeType":"pre","actualEps":1.26},{"date":"2026-07-02","symbol":"YB","amount":1.26,"announcedDate":"2026-06-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-02","defaultRemindTime":1782999000000,"name":"元保","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-28","payableDate":"2026-07-02","currency":"USD","dateTimestamp":1782964800000,"payDate":"2026-07-28"},{"market":"US","date":"2026-06-10","symbol":"YB","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1781064000000,"reportTimeType":"pre","actualEps":1.16},{"market":"US","date":"2026-03-18","symbol":"YB","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773806400000,"reportTimeType":"pre","actualEps":1},{"market":"US","date":"2025-12-03","symbol":"YB","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1764738000000,"reportTimeType":"pre","actualEps":1.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"YB\",market:\"US\",,,undefined,":[{"executeDate":"2026-07-02","recordDate":"2026-07-02","paymentDate":"2026-07-28","value":1.26,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"YB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1771905600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/YB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"YB","date":"2026-09-29","current":2.643301,"percent":0,"low":2.476221,"twenty":3.38696,"median":5.145981,"eighty":6.725869,"high":33.604726,"avg":7.926553,"sd":8.265421,"marketCap":556648828},"quantilePoints":[{"date":"2025-05-02","current":5.678774,"twenty":5.896838,"median":18.920506,"eighty":31.801423,"marketCap":676203015},{"date":"2025-05-09","current":5.564631,"twenty":5.624819,"median":5.678774,"eighty":16.344847,"marketCap":665834568},{"date":"2025-05-16","current":5.501512,"twenty":5.534157,"median":5.621188,"eighty":5.848758,"marketCap":660875746},{"date":"2025-05-23","current":5.481069,"twenty":5.520764,"median":5.603038,"eighty":5.69518,"marketCap":658621736},{"date":"2025-05-30","current":5.712854,"twenty":5.501671,"median":5.603038,"eighty":5.699222,"marketCap":688374669},{"date":"2025-06-06","current":4.749301,"twenty":5.501671,"median":5.618707,"eighty":5.702507,"marketCap":680711035},{"date":"2025-06-13","current":5.73093,"twenty":5.440796,"median":5.603038,"eighty":5.702507,"marketCap":821361262},{"date":"2025-06-20","current":6.845634,"twenty":5.463578,"median":5.622444,"eighty":5.728702,"marketCap":979141965},{"date":"2025-06-27","current":23.11404,"twenty":5.485158,"median":5.641541,"eighty":6.631372,"marketCap":957503469},{"date":"2025-07-03","current":24.179827,"twenty":5.501512,"median":5.655218,"eighty":22.841979,"marketCap":1001682066},{"date":"2025-07-11","current":32.31936,"twenty":5.50191,"median":5.678774,"eighty":22.962968,"marketCap":1337529563},{"date":"2025-07-18","current":28.828696,"twenty":5.533598,"median":5.716321,"eighty":24.20108,"marketCap":1192371316},{"date":"2025-07-25","current":32.553328,"twenty":5.55592,"median":5.769983,"eighty":28.828696,"marketCap":1351053623},{"date":"2025-08-01","current":29.509738,"twenty":5.557798,"median":6.489626,"eighty":29.765086,"marketCap":1217165427},{"date":"2025-08-08","current":29.555462,"twenty":5.564631,"median":22.259818,"eighty":29.765086,"marketCap":1222124249},{"date":"2025-08-15","current":28.969917,"twenty":5.583561,"median":22.861208,"eighty":29.681474,"marketCap":1198546028},{"date":"2025-08-22","current":28.037632,"twenty":5.603038,"median":22.962968,"eighty":29.555462,"marketCap":1159377857},{"date":"2025-08-29","current":6.734807,"twenty":5.614969,"median":22.921624,"eighty":29.681474,"marketCap":1073899084},{"date":"2025-09-05","current":6.545139,"twenty":5.620949,"median":22.861208,"eighty":29.580664,"marketCap":1041873344},{"date":"2025-09-12","current":7.363113,"twenty":5.635145,"median":22.259818,"eighty":29.518883,"marketCap":1175966729},{"date":"2025-09-19","current":6.901715,"twenty":5.639135,"median":7.484606,"eighty":29.499423,"marketCap":1103160011},{"date":"2025-09-26","current":6.054916,"twenty":5.642863,"median":7.077476,"eighty":29.458953,"marketCap":964919408},{"date":"2025-10-03","current":5.349827,"twenty":5.639135,"median":6.977721,"eighty":29.378096,"marketCap":854326926},{"date":"2025-10-10","current":6.375763,"twenty":5.635145,"median":6.890185,"eighty":29.325855,"marketCap":1016990036},{"date":"2025-10-17","current":6.468463,"twenty":5.639135,"median":6.827003,"eighty":29.287579,"marketCap":1032196502},{"date":"2025-10-24","current":6.815287,"twenty":5.642863,"median":6.815287,"eighty":29.249938,"marketCap":1087953545},{"date":"2025-10-31","current":6.64071,"twenty":5.64933,"median":6.80089,"eighty":29.02441,"marketCap":1061918232},{"date":"2025-11-07","current":6.095737,"twenty":5.657913,"median":6.780085,"eighty":28.85694,"marketCap":973444246},{"date":"2025-11-14","current":5.943921,"twenty":5.664517,"median":6.741283,"eighty":28.768689,"marketCap":952477754},{"date":"2025-11-21","current":5.746124,"twenty":5.666614,"median":6.682494,"eighty":28.698792,"marketCap":918839207},{"date":"2025-11-28","current":5.74831,"twenty":5.674,"median":6.64071,"eighty":28.604714,"marketCap":922940345},{"date":"2025-12-05","current":5.443521,"twenty":5.66639,"median":6.570369,"eighty":28.486055,"marketCap":971831439},{"date":"2025-12-12","current":5.306899,"twenty":5.655696,"median":6.478505,"eighty":28.430656,"marketCap":949252140},{"date":"2025-12-19","current":5.173036,"twenty":5.63197,"median":6.441512,"eighty":28.265189,"marketCap":927594446},{"date":"2025-12-26","current":5.161964,"twenty":5.60781,"median":6.394502,"eighty":28.125103,"marketCap":929437654},{"date":"2026-01-02","current":5.17139,"twenty":5.559165,"median":6.333971,"eighty":28.065475,"marketCap":933584872},{"date":"2026-01-09","current":5.085346,"twenty":5.508248,"median":6.291874,"eighty":27.868866,"marketCap":919300009},{"date":"2026-01-16","current":5.169148,"twenty":5.463794,"median":6.251146,"eighty":26.765096,"marketCap":936810486},{"date":"2026-01-23","current":5.252941,"twenty":5.436867,"median":6.114028,"eighty":25.050278,"marketCap":951095348},{"date":"2026-01-30","current":5.04167,"twenty":5.339471,"median":6.054916,"eighty":24.20108,"marketCap":916074395},{"date":"2026-02-06","current":4.798758,"twenty":5.288058,"median":6.029664,"eighty":24.179827,"marketCap":873219808},{"date":"2026-02-13","current":4.962298,"twenty":5.214466,"median":5.943921,"eighty":23.840725,"marketCap":907779959},{"date":"2026-02-20","current":5.033399,"twenty":5.196945,"median":5.905867,"eighty":23.259377,"marketCap":919760811},{"date":"2026-02-27","current":4.819486,"twenty":5.174311,"median":5.869387,"eighty":22.993182,"marketCap":889347879},{"date":"2026-03-06","current":4.985363,"twenty":5.16969,"median":5.797985,"eighty":22.896817,"marketCap":913309583},{"date":"2026-03-13","current":4.831337,"twenty":5.163302,"median":5.77764,"eighty":22.86861,"marketCap":887965473},{"date":"2026-03-20","current":4.063414,"twenty":5.134633,"median":5.746124,"eighty":22.858517,"marketCap":770000158},{"date":"2026-03-27","current":4.216271,"twenty":5.115952,"median":5.735295,"eighty":22.844928,"marketCap":797648279},{"date":"2026-04-02","current":4.663291,"twenty":5.084106,"median":5.717838,"eighty":22.492682,"marketCap":885200661},{"date":"2026-04-10","current":4.563644,"twenty":5.045623,"median":5.712854,"eighty":14.110275,"marketCap":873219808},{"date":"2026-04-17","current":4.353884,"twenty":5.034766,"median":5.674236,"eighty":8.034557,"marketCap":834512440},{"date":"2026-04-24","current":4.175021,"twenty":5.009883,"median":5.665719,"eighty":7.460307,"marketCap":799491487},{"date":"2026-05-01","current":3.970246,"twenty":4.992917,"median":5.654868,"eighty":7.335723,"marketCap":760323316},{"date":"2026-05-08","current":3.799153,"twenty":4.958985,"median":5.639339,"eighty":7.173471,"marketCap":730371185},{"date":"2026-05-15","current":3.400285,"twenty":4.925919,"median":5.620353,"eighty":7.070714,"marketCap":655260458},{"date":"2026-05-22","current":3.373146,"twenty":4.886771,"median":5.603038,"eighty":7.058718,"marketCap":648348428},{"date":"2026-05-29","current":3.404544,"twenty":4.828527,"median":5.564631,"eighty":7.00018,"marketCap":656642864},{"date":"2026-06-05","current":3.53094,"twenty":4.760341,"median":5.552227,"eighty":6.913998,"marketCap":681986974},{"date":"2026-06-12","current":3.597063,"twenty":4.624635,"median":5.50191,"eighty":6.903807,"marketCap":743273642},{"date":"2026-06-18","current":3.361789,"twenty":4.535271,"median":5.497049,"eighty":6.899678,"marketCap":696271837},{"date":"2026-06-26","current":3.260028,"twenty":4.386969,"median":5.45934,"eighty":6.891262,"marketCap":671618929},{"date":"2026-07-02","current":3.661925,"twenty":4.299542,"median":5.440194,"eighty":6.890185,"marketCap":754793692},{"date":"2026-07-10","current":3.245348,"twenty":4.230889,"median":5.415096,"eighty":6.889813,"marketCap":668623716},{"date":"2026-07-17","current":3.119008,"twenty":4.197888,"median":5.336708,"eighty":6.866582,"marketCap":644662011},{"date":"2026-07-24","current":2.99407,"twenty":4.063414,"median":5.306899,"eighty":6.845634,"marketCap":618857099},{"date":"2026-07-31","current":2.949226,"twenty":3.9422,"median":5.288001,"eighty":6.821356,"marketCap":610562663},{"date":"2026-08-07","current":3.037498,"twenty":3.78398,"median":5.237401,"eighty":6.809754,"marketCap":629916347},{"date":"2026-08-14","current":3.001141,"twenty":3.729237,"median":5.205929,"eighty":6.796401,"marketCap":623004317},{"date":"2026-08-21","current":2.966341,"twenty":3.653197,"median":5.193513,"eighty":6.792799,"marketCap":617474693},{"date":"2026-08-28","current":3.0328,"twenty":3.547241,"median":5.174413,"eighty":6.782597,"marketCap":631759555},{"date":"2026-09-04","current":3.012175,"twenty":3.515767,"median":5.172213,"eighty":6.774358,"marketCap":627612337},{"date":"2026-09-11","current":2.796291,"twenty":3.470772,"median":5.169526,"eighty":6.757825,"marketCap":628533941},{"date":"2026-09-18","current":2.505438,"twenty":3.415883,"median":5.163952,"eighty":6.739987,"marketCap":563560858},{"date":"2026-09-25","current":2.488699,"twenty":3.394963,"median":5.154115,"eighty":6.729444,"marketCap":558952838},{"date":"2026-09-29","current":2.476221,"twenty":3.38696,"median":5.145981,"eighty":6.725869,"marketCap":556648828}],"updateTime":1790769192679},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"YB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1150171123","title":"Hashrate Hurdle Rises 4.7%: Bitcoin Must Clear $82,900 to Preserve Miner Margins","url":"https://stock-news.laohu8.com/highlight/detail?id=1150171123","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150171123?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:55","pubTimestamp":1789480532,"startTime":"0","endTime":"0","summary":"Following a profitable August marked by price gains and stronger mining revenue, the Bitcoin network now faces a formidable headwind from an imminent difficulty adjustment. Analysts at Luxor note...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03042","MSBT","BTFX","CBXA","MSTY","BFJL","BITQ","83042","IMST","CBTJ","MSTW","CBTY","NCIQ","BTC","BTCW","ARKY","DEFI","BK4588","OOQB","YB","BPI","MSDD","GBTC","HECO","03008","09439","BCCC","SMST","BETH","CBOY","YBTC","BTRN","MAXI","WNTR","BTCZ","CBTO","MSTC","BK4585","07399","BRRR","BITO","MNRS","07799","CBOJ","NGHT","CRPT","MSST","MBTmain","BTCC","GDLC","MSTU","BTYB","BTF","DFII","FBTC","CBOA","IBIT","BKCH","HODL","BK4601","BTGD","MSTZ","BEGS","BTCL","BITI","BITW","BITC","XBTY","BTCO","03439","BITX","CBTA","EZBC","QBF","BITB","CBXY","YBIT","CBXJ","STCE","WGMI","BITY","09008","BTCI","DAPP","BAGY","MSTP","LFGY","GCPU","MSTX","BITU","MTYY","BFAP","BETE","MSTK","BK4594","TXXH","ARKB","MST","CBXO","BK1611","SBIT","09042","BK4173","MSII","CBOO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666570309","title":"Yuanbao, Inc. Earnings Call Highlights AI-Led Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2666570309","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666570309?lang=en_us&edition=fundamental","pubTime":"2026-09-12 08:10","pubTimestamp":1789171856,"startTime":"0","endTime":"0","summary":"Yuanbao, Inc. Unsponsored ADR (($YB)) has held its Q2 earnings call. Read on for the main highlights of the call. Yuanbao, Inc. Unsponsored ADR del...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-earnings-call-highlights-ai-led-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-earnings-call-highlights-ai-led-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["YB","AGIX","AIPO","QTOC","CHAT","VTHR","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666560629","title":"Yuanbao Q2 FY26 Net Income Rises 35.6% to RMB 413.2 Million; Revenue Increases 30.1% to RMB 1.39 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560629","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560629?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:09","pubTimestamp":1789038558,"startTime":"0","endTime":"0","summary":"Yuanbao Q2 FY26 net income rises 35.6% to RMB 413.2 million; revenue increases 30.1% to RMB 1.39 billionYuanbao posted Q2 2026 revenue of RMB 1.39 billion, up 30.1% year over year.Net income climbed 3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLb0YPLd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666234564","title":"Yuanbao Q2 Adj. EPS $1.32 Up From $0.97 YoY, Sales $205.182M Up From $149.356M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2666234564","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666234564?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:01","pubTimestamp":1789034497,"startTime":"0","endTime":"0","summary":"Yuanbao (NASDAQ:YB) reported quarterly earnings of $1.32 per share. This is a 36.08 percent increase over earnings of $0.97 per share from the same period last year.  The company reported $205.182 million in sales this","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61706785/yuanbao-q2-adj-eps-1-32-0-97-yoy-sales-205-182m-149-356m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666797564","title":"Yuanbao - Q2 2026 Total Revenues up 30.1% to Rmb1,392.2 Mln (us$205.2 Mln)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666797564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666797564?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:00","pubTimestamp":1789034401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUABLNY1X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["YB","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666641175","title":"Yuanbao Inc. Announces Second Quarter 2026 Unaudited Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2666641175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666641175?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:00","pubTimestamp":1789034401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUABLNY1X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4173","YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665353207","title":"Yarrow Bioscience’s YB-101 Trial Targets Graves’ Disease, Raising New Investor Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2665353207","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665353207?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:30","pubTimestamp":1788539458,"startTime":"0","endTime":"0","summary":"Yarrow Bioscience, Inc. ($YARW) announced an update on their ongoing clinical study. The phase 2 study “A Randomized, Blinded, Placebo-Controlled, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yarrow-biosciences-yb-101-trial-targets-graves-disease-raising-new-investor-interest?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yarrow-biosciences-yb-101-trial-targets-graves-disease-raising-new-investor-interest?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4173","YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875893","title":"Yuanbao to Report Q2 2026 Results, Host Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875893","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664875893?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:00","pubTimestamp":1788429635,"startTime":"0","endTime":"0","summary":"Yuanbao to Report Q2 2026 Results, Host Earnings CallYuanbao will report Q2 2026 unaudited financial results on Thursday, Sept. 10, 2026, before the U.S. market open.Management earnings call set for 8","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL3GbnPN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","YB","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BQXX3D17.EUR","SG9999014021.USD","LU2095319765.USD","LU2210149790.SGD","SG9999014013.SGD","BK4585","BCDF","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","BK4173","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4112","LU0314104364.USD","IE00BGHQF748.EUR","BK4588","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875568","title":"Yuanbao Inc. to Announce Second Quarter 2026 Financial Results on Thursday, September 10, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875568","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664875568?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:00","pubTimestamp":1788429600,"startTime":"0","endTime":"0","summary":"BEIJING, Sept.  03, 2026 (GLOBE NEWSWIRE) -- Yuanbao Inc. (“Yuanbao” or the “Company”) (NASDAQ: YB), a leading technology-driven online insurance distributor in China, today announced that it will rel","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355714/0/en/yuanbao-inc-to-announce-second-quarter-2026-financial-results-on-thursday-september-10-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662065979","title":"YB Ventures Malaysia 4th-Quarter 2026 Earnings Summary Table","url":"https://stock-news.laohu8.com/highlight/detail?id=2662065979","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662065979?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:36","pubTimestamp":1787909760,"startTime":"0","endTime":"0","summary":"Figures Are In Ringgit (MYR).Revenue                      13,593,000         15,677,000. PreTax Profit                -3,827,000        -44,830,000. Net Profit                   -7,699,000        -46,955,000. Earnings Per Share            -2.63 Sen         -16.09 Sen. Dividend                       0.00 Sen           0.00 Sen. Revenue                      50,258,000         64,868,000. PreTax Profit               -28,163,000        -63,178,000. Net Profit                  -32,087,000        -65,364,000. Earnings Per Share           -10.98 Sen         -22.39 Sen. Dividend                       0.00 Sen           0.00 Sen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659733155","title":"Press Release: Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659733155","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659733155?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"--  The Company initiated the Phase 2a/2b trial of YB-101 in patients with. Graves' disease , with or without concurrent thyroid eye disease. --  The Phase 2a portion of the trial is a randomized,four cohorts designed to evaluate safety, pharmacokinetics ,pharmacodynamics , and efficacy over 24 weeks, including the. percentage of patients who are euthyroid and off anti-thyroid. drugs, as well as relevant measures of orbitopathy in patients. --  Topline results from the Phase 2a portion of the trial are. --  The Phase 2b portion of the trial is expected to commence in the. --  Licensing partner, Changchun GeneScience Pharmaceutical Co., Ltd.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","LU1169590202.USD","BK4007","BK4023","BK4187","PD","BK4173","BK4218","IDEF","KBWY","GD","PK","LU0170899867.USD","BK4550","BK4585","FOWF","SHLD","BK4516","BK4588","TSHR","YB","BK4566","BK4181","YARW","WDGF","PPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654188596","title":"Yarrow Bioscience initiated with a Buy at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2654188596","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654188596?lang=en_us&edition=fundamental","pubTime":"2026-07-28 23:05","pubTimestamp":1785251123,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Stacy Ku initiated coverage of Yarrow Bioscience (YARW) with a Buy rating. YB-101 is the leading anti-thyroid stimulating hormone ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/yarrow-bioscience-initiated-with-a-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/yarrow-bioscience-initiated-with-a-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4173","COWN","YB","TD","BK4585","BK4207","BK4566","BK4127","GSIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172460343","title":"Yarrow Bioscience Finalizes Merger with VYNE, Starts Phase 2 Trial for Graves' Disease Drug YB-101","url":"https://stock-news.laohu8.com/highlight/detail?id=1172460343","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172460343?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:01","pubTimestamp":1785160880,"startTime":"0","endTime":"0","summary":"Clinical-stage biotechnology company Yarrow Bioscience announced today that it has completed its merger with VYNE Therapeutics, simultaneously closing a roughly $200 million private placement...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VYNE","YARW","YB","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654043338","title":"Yarrow Bioscience Completes VYNE Therapeutics Merger, Begins Phase 2 Trial Dosing for YB-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2654043338","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654043338?lang=en_us&edition=fundamental","pubTime":"2026-07-27 21:17","pubTimestamp":1785158242,"startTime":"0","endTime":"0","summary":"Yarrow Bioscience  said Monday that it has completed its merger with VYNE Therapeutics and the previously announced private financings totaling approximately $200 million.The combined company will operate as Yarrow Bioscience and its shares are expected to begin trading on the Nasdaq Capital Market on Tuesday under the ticker symbol YARW.The combined company will be led by President and Chief Executive Officer Rebecca Frey, Chief Operating Officer Rachael Alford, and Chief Financial Officer Tyler Zeronda.Bill Lundberg, former chief executive of biotech firm Merus, will become chairman of the board of directors.Yarrow said its lead product candidate, YB-101, is a potential first-in-class anti-thyroid-stimulating hormone receptor monoclonal antibody designed to directly disrupt the central mechanism driving both Graves' disease and thyroid eye disease in a single targeted treatment.The company also said it has initiated dosing in a Phase 2a/2b trial of YB-101 in patients with Graves' dis","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VYNE","YARW","YB","BK4007","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654145380","title":"Press Release: Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of Yb-101, a Potential First-in-Class Treatment for Graves' Disease and Thyroid Eye Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2654145380","media":"Dow Jones","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654145380?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:00","pubTimestamp":1785150000,"startTime":"0","endTime":"0","summary":"Yarrow is advancing YB-101--a potential first-in-class anti-TSHR antibody, designed to directly disrupt the central mechanism driving both Graves' disease (\"GD\") and thyroid eye disease (\"TED\")Dosing ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YARW","YB","BK4173","VYNE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648562430","title":"Stocks Ex-dividend July 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2648562430","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648562430?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:56","pubTimestamp":1782852960,"startTime":"0","endTime":"0","summary":"Gl Net Lease Pfd. A           GNLpA        8.0     0.45313. Glbl Net Lease Pfd D          GNLpD        8.1     0.46875. Global Net Lease Pfd E        GNLpE        8.1     0.46094. Global Net Lease Pfd. B       GNLpB        8.0     0.42969. Source: FactSet Dow Jones NewswiresJune 30, 2026 16:56 ET Copyright  2026 Dow Jones & Company, Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","YB","VIG","BK4585","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642585258","title":"Yuanbao, Inc. Earnings Call Highlights AI-Powered Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2642585258","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642585258?lang=en_us&edition=fundamental","pubTime":"2026-06-12 08:12","pubTimestamp":1781223149,"startTime":"0","endTime":"0","summary":"Yuanbao, Inc. Unsponsored ADR (($YB)) has held its Q1 earnings call. Read on for the main highlights of the call. Yuanbao, Inc. Unsponsored ADR del...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-earnings-call-highlights-ai-powered-surge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-earnings-call-highlights-ai-powered-surge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AIPO","YB","CHAT","ARTY","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642423455","title":"Yuanbao Inc. Posts Strong Q1 2026 Results and Deepens AI Push in Online Insurance","url":"https://stock-news.laohu8.com/highlight/detail?id=2642423455","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642423455?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:39","pubTimestamp":1781091572,"startTime":"0","endTime":"0","summary":"The latest update is out from Yuanbao, Inc. Unsponsored ADR ( ($YB) ). Yuanbao Inc., a Chinese technology-driven online insurance distributor, repo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-posts-strong-q1-2026-results-and-deepens-ai-push-in-online-insurance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yuanbao-inc-posts-strong-q1-2026-results-and-deepens-ai-push-in-online-insurance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHAT","YB","AIPO","ARTY","AGIX","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642045447","title":"Yuanbao to remain focused  on high-quality revenue growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2642045447","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642045447?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:17","pubTimestamp":1781086651,"startTime":"0","endTime":"0","summary":"Ray Wan, CFO of Yuanbao (YB), said, “In the Q1, we delivered another strong performance, driven by our continued business expansion and operating e...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/yuanbao-to-remain-focused-on-high-quality-revenue-growth-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/yuanbao-to-remain-focused-on-high-quality-revenue-growth-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["YB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642244770","title":"Yuanbao announces $15M share repurchase program","url":"https://stock-news.laohu8.com/highlight/detail?id=2642244770","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642244770?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:16","pubTimestamp":1781086589,"startTime":"0","endTime":"0","summary":"The Company announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $15M of it...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/yuanbao-announces-15m-share-repurchase-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/yuanbao-announces-15m-share-repurchase-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4173","YB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}